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Comparative study of lactobacilli and bifidobacteria
in vaginal tract of individual with bacterial vaginosis
and healthy control by quantitative PCR
Ashraf Bakhshia,b, Zahra Safayi Delouyia,c, Shiva Taheria,
Azadeh Alivandia,d, Nima Mohammadzadeha,e and Hossein Dabirif
Background: Bacterial vaginosis is characterized by a disequilibrium in vaginal micro-
flora with the distinguishing feature of decrease in lactobacilli. The current study aimed
to study lactobacilli and bifidobacteria in the vaginal tract of individual with bacterial
vaginosis.
Methods: For this purpose, vaginal swabs of 108 women, including 92 patients with
clinical symptoms of bacterial vaginosis and 16 healthy cases were collected. After
extraction of DNA from vaginal samples, quantitative PCR was performed for detect the
bacterial load and 16SrRNA gene. PCR was performed for the detection of micro-
organisms related to sexually transmitted infections, which all samples harboring any of
such microorganisms was excluded from study.
Results: There was a positive link between the quantitation of Lactobacillus spp. and
Bifidobacterium spp. among patients with bacterial vaginosis and healthy group.
Quantitative PCR analysis illustrates that the frequency of Lactobacillus spp. and
Bifidobacterium spp. are significantly lower in patients with bacterial vaginosis com-
pared with healthy individuals.
Conclusion: The current study promotes our understanding about the vaginal Lacto-
bacillus spp. and Bifidobacterium spp. among patients and healthy individuals in Iran.
Confirming the link between the frequency of lactobacilli and bacterial vaginosis could
help us develop new prebiotics and probiotics for this disorder.
Copyright  2019 Wolters Kluwer Health, Inc. All rights reserved.
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Introduction
A miscellaneous collection of microorganisms
compromising the human vaginal microbiota affecting
the health of women along with their sexual partners and
infants [1]. Lactobacilli are regarded as the predominant
microorganisms residing in human vaginal tract, which
subsequently limit the proliferation of pathogenic bacteria
[2]. The production and assembly of lactic acid by these
bacteria contribute to a pH level of 4.5 or lower, which is
favorable for vaginal environment and could prevent the
profusion of bacteria [3,4]. Moreover, the growth of
various bacteria is hindered by proteins with low
molecular weight called bacteriocins produced by
lactobacilli, which it causes the permeability of the cell
membrane of Gram-negative bacteria [5,6]. Some of
these microorganisms, specifically Lactobacillus crispatus
can also produce hydrogen peroxide aerobically, which
can impede the growth of anaerobes by forming strong
oxidants along with host myeloperoxidase and chloride
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[7,8]. Lactobacillus vaginalis and Lactobacillus jensenii are two
major hydrogen peroxide producers during pregnancy
[9]. In addition, the abundance of lactobacilli and their
attachment to glycolipids of epithelia restricts other
bacteria from attaching to vaginal epithelia [10,11].
Bacterial vaginosis is considered as a disorder generated by
alteration in microbial constitution of vagina, which is
distinguished by decrease in Lactobacillus spp. counts due
to immoderate douching [12], spermicides application
(such as nonoxynol-9) [13], antibiotic use [14] and other
factors providing sufficient space for the proliferation of
anaerobic bacteria, such as Atopobium spp., Gardnerella
spp., Prevotella spp. and Papillibacter spp. [15,16]. Bacterial
vaginosis could be a troublesome condition as it has been
linked with susceptibility for developing sexually
transmitted infections (STIs) and acquisition of infections
with Neisseria gonorrhea, Trichomonas vaginalis, Chlamydia
trachomatis and herpes simplex virus type 2 [17]. Preterm
birth [18], pelvic inflammatory disease [19] and
pregnancy-related endometritis [20] are also another
reported adverse health outcomes associated with
bacterial vaginosis. Microorganisms causing bacterial
vaginosis and their concomitant toxins have the ability to
cross the placenta hence may have neurological outcomes
on the fetus brain [21,22]. Antibiotics, including
clindamycin and metronidazole are considered as the
common treatment for bacterial vaginosis; however,
regular recurrence of disease may be due to a lack of
understanding about characteristics of the lesion [23,24].
Bifidobacteria provide protection from pathogens in the
gastrointestinal tube (GIT) through the production of
bacteriocins, inhibition of pathogen adhesion and modu-
lation of the immune system [25]. Due to these health-
promoting effects, bifidobacteria have been extensively
studied as probiotics. Although a healthy vaginal micro-
biota is defined as Lactobacillus dominated, several studies
have identified vaginal Bifidobacterium-dominated profiles
in 5–10% of healthy, reproductive aged women [25].
To date, culture-based or culture-independent molecular
techniques, including the analysis of 16SrRNA gene has
been used frequently by researchers to investigate the
vaginal microbiota [26]. As culture is considered as an
arduous method, making it an inappropriate for
researches in larger scales. Therefore, methods based
on 16SrRNA gene have recently been used vastly, which
can also give us an insight about the quantitation of
microorganisms [27].
We sought to evaluate the molecular markers for bacterial
vaginosis, including the frequency of Lactobacillus spp.
group and to determine the correlation between this
disorder and the frequency of Bifidobacterium spp. and to
see whether this microorganism is a contributor to the
bacterial vaginosis. Results could be deployed for
developing a molecular diagnostic test for bacterial
vaginosis and to compare them with the clinical diagnosis
of this disorder and to provide a better understanding of
vaginal microbiota in patients with low income.
Materials and methods
Study participants and sample collection
In this study, vaginal swabs of 108 women, including 92
patients with clinical symptoms of bacterial vaginosis and
16 healthy individuals without any clinical symptoms
were collected. Vaginal samples were obtained from adult
female individuals, who referred to a gynecology clinic
affiliated to Akbar Abadi Hospital, Tehran, Iran. Samples
were collected by two sterile cotton swab from vaginal
walls after inserting a sterile speculum into the vagina.
One swab was inserted in a tube containing 1ml of PBS
and was readily stored at 80 8C. The other swab was
rolled on a slide for further microscopy examinations.
After removing the speculum, remnants of vaginal
secretions were used for Potassium hydroxide (KOH)
test and pH evaluations. Bacterial vaginosis was defined
by the presence of three out of four of the followings
factors: first, the observance of homogenous white
vaginal secretions; second, presence of malodorous like
fishy odor after addition of 10% KOH; third, pH more
than 4.5; and fourth, existence of clue cells on slide under
microscopic examinations. Patients who had clinical
manifestations of bacterial vaginosis and referred to the
hospital were excluded from the study. In addition,
patients who had used antibiotics in past 2 weeks or were
in their menstruation cycle were excluded from this study.
To further investigate, some issues such as educational
level, occupation, frequency of sexual intercourse,
smoking and drinking alcohol were evaluated.
Extraction of total DNA from vaginal samples
Total microbial DNAwas extracted from vaginal samples
by means of PureLinkMicrobiomeDNA Purification Kit
(Invitrogen, Waltham, Massachusetts, USA) according to
the manufacturer’s protocol. Nanodrop spectrophotom-
eter (Nanodrop Technologies, Wilmington, Delaware,
USA) and agarose gel-electrophoresis were used for
evaluation of DNA quality and concentrations. Extracted
DNA were immediately stored at 20 8C until next use.
Screening of sexually transmitted infection
infections
PCR was performed in a DNA thermal cycler (Bio-Rad,
Hercules, California, USA) for the detection of micro-
organisms related to STI. Some of the specific primers
were designed and administered for bacterial and viral 16S
rRNA in this investigation using various databases,
including www.ncbi.nlm.nih.gov, www.arb-silva.de and
AlleleID software (version 7.5) (Premier Biosoft, USA).
Sequences were then aligned by blast.ncbi.nih.gov
website. Sequences of primers are shown in Table 1.
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Real-time quantitative PCR and microbial
quantification
By employing genus specific 16S rRNA primers, real-
time quantitative PCR (qPCR) was performed in Rotor-
Gene 6000 real-time PCR cycler (Qiagen Corbett,
Hilden, Germany) for determination of bacterial quantity
in patients with bacterial vaginosis and healthy individu-
als. All tests were performed in triplicates and mean values
were used for further analysis. Each reaction tube with
a total volume of 20ml was consisted of 10ml of
2TaqMan universal PCR master mix (Applied
Biosystems, Foster City, California, USA), 1ml of each
primer and probe (in a final concentration of 0.25mmol/
l), 2ml of sterilized ultrapure nuclease-free water, and 5ml
of extracted DNA. Negative controls were also prepared,
which included aforementioned except for the template
DNA. The following conditions were provided for real-
time qPCR: an initial holding at 95 8C for 30 s, followed
by 40 cycles of denaturation at 95 8C for 5 s and
annealing/extension at 60 8C for 30 s. Oligonucleotide of
primers and probs are shown in Table 2.
Standard curves
Standard curves were constructed for determination of the
number of Lactobacillus spp. and Bifidobacterium spp. present
in each sample using 10-fold serial dilutions of bacterial
standard strains genomic DNA of known concentration
from pure cultures, corresponding to 101 to 1010 Copies
per 200ml vaginal sample. Standard curves were created
according to Applied Biosystems tutorials and normalized
to the copy number of the 16SrRNA gene for each species.
For the species which copy number of 16S rRNA operon
was not published, the copy number was calculated by
averaging the operon numbers of the closest bacterial taxa
from the ribosomal RNA database rrnDB. The bacterial
concentration from each vaginal sample were calculated
from the threshold cycle values (Ct) obtained from the
standard curves and expressed as quantity of bacteria per
200ml vaginal sample [29].
Statistical analysis
In this study, independent t test was used to assess the
mean equivalence of age variant in both groups of
bacterial vaginosis patients and healthy individuals based
on the normalized data. Also, nonparametric Mann–
Whitney test was used to assess the differences in
Lactobacillus spp. and Bifidobacterium spp. among patients
with bacterial vaginosis and healthy group. All statistical
analyses were carried out by SPSS software version 24.0
(SPSS, Chicago, Illinois, USA).
Results
Patients
In this study, we performed the relevant assays for the
diagnosis of bacterial vaginosis. Twenty-one patients with
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Table 1. Sequences of designed primers and their Tm in this study for PCR.
Organisms Forward primer sequence Reverse primer sequence Tm Size (bp) Ref.
Neisseria gonorrhea GACGATCAGTAGCGGGTCTG CTTGCGCCCATTGTCCAAAA 59 107 This study
Chlamydia trachomatis TGTCTGACGGTTCTTAAGCTGG TTGGTTGATCGCCCAGACAAT 59 127 This study
Treponema pallidum GAAGGCCAAAGCGGAAAAGG CGAGGACACAAGCGAGAGTT 57 232 This study
Ureaplasma urealyticum ACGGCTTAGTTAACGGCAAAAC GTCTCCTAATCTAACGCTATCACCA 60 147 This study
Trichomonas vaginalis GAGTTAGGGTATAATGTTTGATGTG AGAATGTGATAGCGAAATGGG 58 337 This study
Gardnerella vaginalis GCAAGCCTTTTGGGTGAGTG TTTCGCTTCTCAGCGTCAGT 57 303 This study
HSV-1 TGCAGAGCAACCCCATGAAG ATGACCATGTCGGTGACCTTGG 56 241 [19]
HSV-2 TACGCTCTCGTAAATGCTTC GCCCACCTCTACCCACAA 56 120 [28]
HHV-6 AATAGGAGCCTTGCTGGTCAGAAC CCTGGAACCCCACAAAACCTAACG 57 369 [19]
HPV-16 GACAAGCAGAACCGGACAGA GAGAACAGATGGGGCACACA 59 159 [17]
HPV-18 AGAAAGCTCAGCAGACGACC CACACCACGGACACACAAAG 59 77 [17]
HSV-1, herpes simplex virus-1; HSV-2, herpes simplex virus-2; HHV-6, human herpes virus-type 6; HPV-16, human papilloma virus-type 16; HPV-
18, human papilloma virus-type 18.
Table 2. Oligonucleotide sequence primers and their Tm in this study for real-time PCR.
Organisms
Primer
Proba Oligonucleotide sequence Tm Size (bp) Ref.
Lactobacilli Primer F
Primer R
Probe
GTCTGATGTGAAAGCCYTCG
CCAGGGTATCTAATCCTGTTYG
YCACCGCTACACATGRAGTTCCACT
60 204 [28]
Bifidobacteria Primer F
Primer R
Probe
GGTTAACTCGGAGGAAGG
GTACCGGCCATTGTAGCA
CGTCAGATCATCATGCCCCTTACG
60 85 [28]
aPrimers F (forward), R (reverse) and probes targeting the 16S rDNA gene.
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bacterial vaginosis were diagnosed. Five people with STI
diagnosed and excluded from study, and 16 patients with
bacterial vaginosis were enrolled in the study. Patients
with bacterial vaginosis and healthy controls were aged
between 22 and 60 (31.5 10.7).
Screening of sexually transmitted infection
Based on PCR results, the prevalence of STI-related
microorganisms in vaginal specimens of patients with
bacterial vaginosis were as follow: herpes simplex virus-2
(9.52%, N¼ 2), Human papilloma virus (4.76%, N¼ 1),
N. gonorrhea (4.76%, N¼ 1) and T. vaginalis (4.76%,
N¼ 1). All positive samples were excluded from further
analysis for detection of Bifidobacterium spp. and Lactoba-
cillus spp. as they might affect the quantity of these bacteria
(Fig. 1).
Real-time quantitative PCR analysis of
lactobacilli and bifidobacteria groups
The results of Real-time qPCR analysis of Lactobacillus
and Bifidobacterium spp. in patients with bacterial vaginosis
and healthy individuals revealed that there are statistically
significant differences in copy number of these species
among patients with bacterial vaginosis and healthy group
(P< 0.001).
Independent t test analysis
The evaluation of the mean equivalence of age variant in
both groups of bacterial vaginosis patients and healthy
individuals indicated that there are no statically significant
differences at 95% confidence level.
Mann–Whitney test analysis
Evaluation of the differences in Lactobacillus spp. and
Bifidobacterium spp. among patients with bacterial
vaginosis and healthy group indicated that there are
significant differences among these two groups among
both bacterial groups (Table 3). Mean differences in
Lactobacillus spp. and Bifidobacterium spp. in patients with
bacterial vaginosis and healthy group are demonestrated
in Fig. 2.
Discussion
Vaginal tract is thought to be predominated by
Lactobacillus spp., which seems as a shield of vaginal
environment from infections; however, it does not
entirely inhibit the colonization of other microorganisms.
Studies have shown that different environmental factors,
including interactions between bacteria and host immune
The detection of lactobacilli and bifidobacteria in vaginal tract Bakhshi et al. 151
Fig. 1. Sample screening for this study.
Table 3. Statistical results of the bacterial vaginosis and nonbacterial vaginosis groups.
Copies per 200ml vaginal sample Mann–Whitney test
Bacterial species Case, N¼16 Control, N¼16 Z Sig
Lactobacillus spp. 2.9Eþ105.9Eþ10 6.6Eþ102.5Eþ11 2.42 0.015
Bifidobacterium spp. 4.8Eþ098.6Eþ09 2Eþ115.5Eþ11 3.65 <0.001
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system along with regular douching, multiple sex partners
and hormone levels can have an effect on the equilibrium
of vaginal microbiota [30]. Although distinguished
community outline exist, bacterial species are not
invariably shared in vaginal tract of women. Here we
studied the abundance of Lactobacillus spp. and Bifido-
bacterium spp. in patients with bacterial vaginosis and
healthy individuals by qPCR assay to substantiate and
expand prior studies on this subject. We verified that the
abundance of lactobacilli group is significantly higher in
women with healthy vaginal tract compared with the
patients suffering from bacterial vaginosis and showed
that Bifidobacterium spp., another constituent of vaginal
microbiota, was lowered in patients with bacterial
vaginosis. However, frequency of Lactobacillus spp. was
not lowered in a patient with bacterial vaginosis disorder,
which could be explained by various factors such as diet,
life style and medical history or defects in bacterial
vaginosis diagnosis.
Studies suggested that Lactobacillus spp. in the vaginal
microbiota primarily consist of five different species,
including Lactobacillus iners, L. crispatus, L. jensenii or
Lactobacillus gasseri [7,31–33]. In a study conducted by
Srinivasan et al. [32], L. iners was detected in 90% of
women and the only Lactobacillus species, which had no
strong correlation with the absence of bacterial vaginosis.
Also, the vaginal tract of women without bacterial
vaginosis was dominated by L. crispatus and L. iners.
Another research conducted by De Backer et al. [34],
which vaginal microflora categorized by Gram stain
according to criteria described by Verhelst et al. [35]. The
results of their study among 71 vaginal microflora samples
were as follows: grade Ia: 8 samples, grade Iab: 10, grade
Ib: 13, grade I-like: 10, grade II: 11, grade III: 12 and
grade IV: 7. L. crispatuswas found in vaginal samples of all
grades, including normal flora and disturbed vaginal
microflora and was found to be the most frequent
lactobacillus species detected. L. jensenii was found in 46%
of samples, but no correlation was found between L.
jensenii and either normal or vaginal microflora. Overall
L. gasseri and L. iners are abundantly present in most
grades. Strikingly, L. gasseri is virtually absent in grade III,
whereas L. iners is virtually absent in grades Ia and II [34].
Another study by Ling et al. showed that there was a
profound shift of lactobacilli present in the vagina when
comparing populations associated with healthy and
diseased conditions [36]. In the bacterial vaginosis-
positive samples, lactobacilli was reduced significantly,
and even disappeared in some samples (P< 0.05). One of
the Lactobacillus spp., L. iners, was a major component of
the vaginal microbiota in healthy women and decreased
markedly in bacterial vaginosis-positive samples
(P< 0.05), whereas two other predominant species (L.
crispatus and L. jensenii) were also reduced in bacterial
vaginosis-positive samples, but did not reach statistical
significance (P< 0.05) [36].
In another study by Santiago et al., L. crispatuswas present
in high concentrations when the vaginal microflora Gram
stain was grade Ia, Iab or II and the concentrations clearly
declined during the menses of the nine women, who
were predominantly colonized by L. crispatus. L. iners,
present in all 17 women, had an almost inverse pattern
compared with L. crispatus: in women with normal
vaginal microflora, it was largely absent, or barely (only
around the menses) present [37].
Zozaya-Hinchliffe et al., indicated that vaginal microbial
communities of clinically healthy patients are predomi-
nated by Lactobacillus spp. while those of bacterial
vaginosis patients are predominated by non-Lactobacillus
spp. [38], which was in accordance with our study.
To our understanding there has been no study on
evaluating the quantity of bifidobacteria among bacterial
vaginosis patients and healthy individuals. However, our
study showed significant differences among these groups.
The frequency of these bacteria were not drastic,
therefore it could be concluded that the overgrowth of
other anaerobe bacteria limited the space for Bifidobacter-
ium spp. growth. One suggestion for the improvement of
bacterial vaginosis disorder could be the application of
probiotics. Hence, many researchers have studied the use
of compounds comprising lactobacilli for improving the
health of vagina and ameliorating outcomes, but results
were shown to be controversial [39].
Recently a study reported that the prevalence of vaginal
bifidobacteria occurred significantly high in women with
bacterial vaginosis than healthy group [40]. However, our
study showed the contrary results to the aforementioned
study that means significantly low amount of vaginal
bifidobacteria has been detected in women with bacterial
vaginosis, which may result from cultural differences and
sex behavior. In addition, from historical studies of
152 Reviews in Medical Microbiology 2019, Vol 30 No 3
Fig. 2. Mean differences in Lactobacillus spp. and Bifido-
bacterium spp. in patients with bacterial vaginosis and
healthy group.
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bacterial vaginosis, no single bacterial species is present
during all cases of bacterial vaginosis by any definition.
Therefore, no single bacterium could be considered a
specific marker for the diagnosis of bacterial vaginosis,
and the interaction between microorganisms acting in
consort in the human vaginal environment needs to be
considered [41].
In addition, after screening of samples for the presence of
STI-related microorganism infections were detected.
This was in contrast with the practice of having only one
sexual partner throughout life, which is common in Iran.
However, this could suggest that unprotected sexual
behaviors among partners outside marriage have
increased drastically. A shortcoming of this study was
that Lactobacillus spp. were detected by primers designed
for the whole family of lactobacillaceae. Further studies
for the detection of Lactobacillus spp., which are only
specific to human vaginal tract could help us reach to a
better understanding of the a link between studied
bacteria and bacterial vaginosis.
Conclusion
qPCR analysis illustrates that the frequency of Lactobacillus
spp. an Bifidobacterium spp. are significantly lower in
patients with bacterial vaginosis compared with healthy
individuals. Results of this study promote our under-
standing about the vaginal Lactobacillus and Bifidobacterium
species among patients and healthy individuals in Iran.
Confirming the relationship between the frequency of
lactobacilli and bacterial vaginosis could help us develop
new prebiotics and probiotics for this disorder.
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